762. Deputy Paul Nicholas Gogarty asked the Minister for Health the steps being taken to recruit and retain public health nurses to support the school vaccination programme; and whether a workforce assessment has been undertaken to determine the number of additional nurses required to ensure the timely delivery of school-based immunisations nationwide. [71761/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Paul Nicholas Gogarty .
73 questions match, newest first.
763. Deputy Paul Nicholas Gogarty asked the Minister for Health the extent to which shortages of public health nurses have affected the delivery of the school vaccination programme, including the HPV, Tdap, MenACWY and other routine school-based vaccinations, in each of the past three school years; and the number of schools where vaccination clinics were postponed or delayed due to staffing shortages. [71760/26]
766. Deputy Paul Nicholas Gogarty asked the Minister for Health the number of sanctioned public health nurse posts that are currently vacant, by CHO7 health region; the number of vacancies specifically affecting the delivery of the school immunisation programme; and the measures being taken to address staffing shortages. [71763/26]
767. Deputy Paul Nicholas Gogarty asked the Minister for Health if she will provide a breakdown, by HSE CHO7 region, of the number of public health nurses assigned to the school vaccination programme; the recommended staffing levels for each region; and the current staffing deficit. [71762/26]
773. Deputy Paul Nicholas Gogarty asked the Minister for Health the measures being taken to ensure consistency in eligibility criteria among providers of a service (details supplied) funded by the HSE, particularly in relation to geographic catchment areas and access to services by older persons living near catchment boundaries. [71786/26]
774. Deputy Paul Nicholas Gogarty asked the Minister for Health the number of HSE-funded providers of a service (details supplied) operating in Dublin; the catchment area applicable to each provider; and whether such catchment areas are mandated by the HSE or determined locally. [71785/26]
775. Deputy Paul Nicholas Gogarty asked the Minister for Health whether a person who resides outside the catchment area of a local service provider (details supplied) may avail of the service where they regularly attend a day centre, community service or other facility within the provider's catchment area. [71783/26]
776. Deputy Paul Nicholas Gogarty asked the Minister for Health whether there is a national policy governing the catchment areas operated by service providers (details supplied) funded by the HSE; and if so, to provide details of same. [71782/26]
826. Deputy Paul Nicholas Gogarty asked the Minister for Health whether consideration is being given to the development of a national framework to support access to GPS locating technology and other assistive safeguarding devices for vulnerable children who are assessed as being at significant risk of wandering or absconding; whether any pilot projects or reviews are underway in this area. [68826/26]
437. Deputy Paul Nicholas Gogarty asked the Minister for Health if she will provide new funding to Diabetes Ireland to employ two psychologists to further support delivery of its Mental Health and Wellbeing Programmes to people living with diabetes and their parents/carers. [67685/26]
438. Deputy Paul Nicholas Gogarty asked the Minister for Health if she will sanction a HIQA Health Technology Assessment on the effectiveness and long term health benefits of continuous glucose monitoring (CGM) for people with other types of diabetes, such as type 2 diabetes, cystic fibrosis-related diabetes, type 3c diabetes and so on, using daily insulin injections (basal-bolus) to potentially expand access to CGM …
439. Deputy Paul Nicholas Gogarty asked the Minister for Health if she will make continuous glucose monitoring (CGM) available to women with type 2 diabetes (approximately 300 women per year) for the duration of their pregnancy to minimise the health risks for mother and baby. [67682/26]
440. Deputy Paul Nicholas Gogarty asked the Minister for Health if she will provide new funding to provide a new registered advanced nurse practitioner post in each young adult diabetes clinic in all level 4 hospitals to support the further development of each local service. [67681/26]
442. Deputy Paul Nicholas Gogarty asked the Minister for Health if she plans to begin the implementation of the National Diabetes Strategy by providing funding to create a Regional Diabetes Clinical Lead post in each HSE Health Region in the upcoming budget. [67678/26]
443. Deputy Paul Nicholas Gogarty asked the Minister for Health if she will remove the specific criteria of 'insulin initiation from the start' that is preventing approximately 500-700 people with a clinical diagnosis of type 1 diabetes from accessing continuous glucose monitoring (CGM), which clinical evidence and recommendations overwhelmingly supports as first-choice glucose monitoring treatment for all people wit…
1102. Deputy Paul Nicholas Gogarty asked the Minister for Health the number of WTE registrars in neurology based at Tallaght University Hospital as of 31 August 2026, in tabular form. [64188/26]
1104. Deputy Paul Nicholas Gogarty asked the Minister for Health the number of WTE consultant anaesthesiologists based at CHI Crumlin as of 31 August 2026, in tabular form. [64186/26]
1111. Deputy Paul Nicholas Gogarty asked the Minister for Health the engagement that has taken place between her Department, the HSE, clinicians, patient organisations and the manufacturer of a medication (details supplied) regarding access to the treatment of patients with Von Hippel-Lindau (VHL) disease; whether interim or compassionate access arrangements are being considered pending a reimbursement decision; and …
1112. Deputy Paul Nicholas Gogarty asked the Minister for Health the steps being taken by her Department and the HSE to ensure timely and equitable access to a medication (details supplied) for eligible patients with Von Hippel-Lindau (VHL) disease, in view of its potential to reduce the need for repeated surgeries and improve quality of life; and if she will make a statement on the matter. [64204/26]
1113. Deputy Paul Nicholas Gogarty asked the Minister for Health the current status of the assessment, appraisal and reimbursement process for a medication (details supplied) for the treatment of patients with Von Hippel-Lindau (VHL) disease; the timeline for a decision on its approval and reimbursement; and if she will make a statement on the matter. [64203/26]
275. Deputy Paul Nicholas Gogarty asked the Minister for Health her plans to introduce a vaccine injury payment programme in Ireland; and if she will make a statement on the matter. [49935/26]
276. Deputy Paul Nicholas Gogarty asked the Minister for Health if a timeline for when the vaccine injury payment programme may be introduced; and if she will make a statement on the matter. [49936/26]
823. Deputy Paul Nicholas Gogarty asked the Minister for Health the actions she is taking in liaison with the HSE to ensure a timely pricing and reimbursement scheme for givinostat (duvyzat), given that it is a year since conditional marketing authorisation was granted and it is a year since she met with families of children with DM and MDI and six months since she spoke at a national conference (details supplied); a…
824. Deputy Paul Nicholas Gogarty asked the Minister for Health the reasons provided by the HSE regarding the delay in processing the pricing and reimbursement application for givinostat, especially since 15 January 2026 when a full HTA dossier was submitted by a company (details supplied) to the NCPE; and if she will make a statement on the matter. [44892/26]
825. Deputy Paul Nicholas Gogarty asked the Minister for Health if she has been briefed by the HSE Drugs Group which was due to meet on 10 June 2026 to consider givinostat for reimbursement; if clear timelines for rollout have now been provided; if there will be proactive engagement with the HSE and clinical teams to ensure planning begins urgently, in order that implementation does not become a further barrier to ac…